Further to stringent review and approval of several DiagCor Life Science IVD products by the Saudi Arabia Food and Drug Authority (SFDA, https://www.sfda.gov.sa/en) of Saudi Arabia last year, we are excited to announce a successful installation and customer training of our GenoFlowTM HPV Array and GenoFlowTM STD Array solutions at one of the prestigious hospitals in Jeddah, Saudi Arabia. The hospital customer will be running our full solution of DiagPuroTM Nucleic Acid Extraction System and reagent, Genesis 96T Thermal Cycler and FTPRO Auto System to provide daily clinical service for HPV and STD testing.
Thanks to the expertise and persistence of our Saudi Arabia distributor, we were able to win this important tender, and execute the successful delivery and training to this new customer. By continuing to work closely with our local partner, we look forward to developing this site into a key reference laboratory among the Middle East regions.
Acerca de DiagCor
Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.
Contacto de prensa
DiagCor Life Science